Cargando…
LncRNA NR2F1‐AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR‐363
Emerging evidence has validated the vital role of long non‐coding RNA (lncRNA) in the chemoresistance of cancer treatment. In the present study, we investigate the function of lncRNA NR2F1‐AS1 on oxaliplatin (OXA) resistance of hepatocellular carcinoma (HCC) and discover the underlying molecular mec...
Autores principales: | Huang, Hai, Chen, Jie, Ding, Cheng‐Ming, Jin, Xin, Jia, Ze‐Ming, Peng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980138/ https://www.ncbi.nlm.nih.gov/pubmed/29602203 http://dx.doi.org/10.1111/jcmm.13605 |
Ejemplares similares
-
The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐363‐3p in gallbladder cancer
por: Wang, Shou‐Hua, et al.
Publicado: (2016) -
Role of lncRNA NR2F1-AS1 and lncRNA H19 Genes in Hepatocellular Carcinoma and Their Effects on Biological Function of Huh-7
por: Ji, Wen-Chao, et al.
Publicado: (2021) -
lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p
por: Zhang, Zhenming, et al.
Publicado: (2020) -
lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p
por: Hou, Chao, et al.
Publicado: (2020) -
The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis
por: Li, Dandan, et al.
Publicado: (2022)